Irén K.
- Country
- Hungary
- Department
- Gyermekosztály
Research Overview
- A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in Pediatric Participants (ages 10 to 17 years, inclusive) with Type 2 Diabetes Mellitus (MK-8835-059/B1521066)
- A 52-week randomized, double-blind, placebo-controlled, multi-center Phase 2b study with a 52-week blinded extension and an optional open-label extension—assessing the safety and efficacy of frexalimab, a CD40L-antagonist monoclonal antibody, for the preservation of pancreatic β-cell function in adults and adolescents with newly diagnosed type 1 diabetes on insulin therapy
- Evaluation of Diamyd (Recombinant Human Glutamate Decarboxylase 2) and Colecalciferol in Preserving Beta Cell Function in HLA DR3-DQ2 Positive Type 1 Diabetes
Data & Insights
Has run more than one trial at 15 of 95 partner sites.
Specializations
Diabetes Management
This investigator specializes in both Type 1 and Type 2 diabetes treatment approaches, with particular emphasis on innovative therapeutic interventions for diabetes management.
- Endogenous insulin preservation strategies
- Beta cell function assessment
- Glycemic control optimization
Their research encompasses novel treatments for maintaining natural insulin production in newly diagnosed patients.
Pediatric and Adolescent Medicine
The investigator focuses on diabetes treatments specifically tailored for younger populations, including adolescents and young adults aged 12-21 years.
- Pediatric diabetes therapeutics
- Age-specific treatment protocols
- Adolescent medical care
Their work addresses the unique challenges of managing diabetes in younger patient populations.
Immunological Research
The investigator has expertise in immunological aspects of diabetes, particularly focusing on genetic and antibody-related factors in treatment response.
- HLA haplotype assessment
- GAD65 antibody studies
- Immune system modulation
Their research includes investigation of genetic markers and immunological factors in diabetes treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.